Publicacións nas que colabora con Francisco Javier Rodríguez Berrocal (29)

2022

  1. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

    Cancers, Vol. 14, Núm. 19

2020

  1. Value of serum NEUROG1 methylation for the detection of advanced adenomas and colorectal cancer

    Diagnostics, Vol. 10, Núm. 7

2018

  1. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples

    Clinical Epigenetics, Vol. 10, Núm. 1

2017

  1. Highly sensitive marker panel for guidance in lung cancer rapid diagnostic units

    Scientific Reports, Vol. 7

  2. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis

    BMC Cancer, Vol. 17, Núm. 1

2016

  1. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer

    Scientific Reports, Vol. 6

  2. Mineral water disinfection using ultrasound

    Libro de actas del I Congreso Internacional del Agua "Termalismo y Calidad de Vida": Ourense (España), 23-24 de septiembre de 2015 (Universidade de Vigo), pp. 73-80

2015

  1. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening

    Scientific Reports, Vol. 5

  2. Serum sCD26 for colorectal cancer screening in family-risk individuals: Comparison with faecal immunochemical test

    British Journal of Cancer, Vol. 112, Núm. 2, pp. 375-381

2014

  1. Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients

    PLoS ONE, Vol. 9, Núm. 9

2010

  1. Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas

    BMC Cancer, Vol. 10

2009

  1. Soluble CD26 levels and its association to epidemiologic parameters in a sample population

    Disease Markers, Vol. 27, Núm. 6, pp. 311-316

2008

  1. How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer

    Anticancer Research, Vol. 28, Núm. 4 C, pp. 2333-2341

2007

  1. Absence of activating mutations in the EGFR kinase domain in spanish head and neck cancer patients

    Tumor Biology, Vol. 28, Núm. 5, pp. 273-279

2005

  1. Application of relative warp analysis to the evaluation of two-dimensional gels in proteomics: Studying isoelectric point and relative molecular mass variation

    Journal of Proteome Research, Vol. 4, Núm. 4, pp. 1318-1323

2004

  1. Clinical significance of preoperative serum sialic acid levels in colorectal cancer: Utility in the detection of patients at high risk of tumor recurrence

    International Journal of Biological Markers, Vol. 19, Núm. 1, pp. 38-45

2003

  1. Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma

    Oncology Reports, Vol. 10, Núm. 5, pp. 1345-1350

  2. Purification of human alpha-L-fucosidase precursor expressed in Escherichia coli as a glutathione S-transferase fusion protein

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 786, Núm. 1-2, pp. 7-15

2002

  1. Activity and properties of α-L-fucosidase are dependent on the state of enterocytic differentiation of HT-29 colon cancer cells

    International Journal of Biochemistry and Cell Biology, Vol. 34, Núm. 10, pp. 1291-1303

  2. Lectin isolation and detection of N-glycoproteins bearing sialic acid and L-fucose residues in human colorectal mucosa and in adenocarcinoma biopsies.

    International journal of oncology, Vol. 20, Núm. 2, pp. 367-372